Education
About Us
Working with TipRanks
Follow Us
Mabpharm Limited (HK:2181)
:2181
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 258.23M | ¥ 87.16M | ¥ 55.92M | ¥ 82.88M | ¥ 0.00 |
| Gross Profit | ¥ 219.39M | ¥ 75.24M | ¥ 40.54M | ¥ 66.11M | ¥ 0.00 |
| Operating Income | ¥ -119.67M | ¥ -201.98M | ¥ -226.25M | ¥ -297.52M | ¥ -186.21M |
| EBITDA | ¥ -67.81M | ¥ -139.08M | ¥ -152.08M | ¥ -245.46M | ¥ -169.93M |
| Net Income | ¥ -127.95M | ¥ -209.36M | ¥ -210.62M | ¥ -291.74M | ¥ -188.57M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 89.34M | ¥ 173.34M | ¥ 48.61M | ¥ 81.56M | ¥ 484.85M |
| Total Assets | ¥ 1.02B | ¥ 1.03B | ¥ 917.52M | ¥ 899.90M | ¥ 1.16B |
| Total Debt | ¥ 293.09M | ¥ 260.07M | ¥ 126.34M | ¥ 46.43M | ¥ 40.35M |
| Net Debt | ¥ 203.75M | ¥ 86.73M | ¥ 92.77M | ¥ -35.13M | ¥ -444.50M |
| Total Liabilities | ¥ 927.28M | ¥ 829.92M | ¥ 516.58M | ¥ 297.92M | ¥ 281.55M |
| Stockholders' Equity | ¥ 88.93M | ¥ 205.06M | ¥ 400.94M | ¥ 601.98M | ¥ 881.49M |
| Cash Flow | |||||
| Free Cash Flow | ¥ -63.58M | ¥ 38.35M | ¥ -182.01M | ¥ -348.14M | ¥ -344.47M |
| Operating Cash Flow | ¥ -4.10M | ¥ 57.39M | ¥ -56.88M | ¥ -199.47M | ¥ -147.23M |
| Investing Cash Flow | ¥ -98.20M | ¥ -3.50M | ¥ -104.95M | ¥ -179.42M | ¥ 156.00M |
| Financing Cash Flow | ¥ 18.28M | ¥ 85.60M | ¥ 112.26M | ¥ -17.78M | ¥ -80.48M |